Stonepine Capital Management, LLC - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$19,222,000
+35.1%
3,914,938
+45.3%
8.75%
+17.6%
Q2 2021$14,226,000
-13.3%
2,694,295
-21.2%
7.44%
-16.1%
Q1 2021$16,408,000
+368.7%
3,418,279
+322.8%
8.86%
+230.7%
Q4 2020$3,501,000
+29.2%
808,431
+23.0%
2.68%
-4.9%
Q3 2020$2,709,000
+39.6%
657,467
-13.2%
2.82%
-25.0%
Q2 2020$1,940,000
-42.3%
757,704
-34.8%
3.76%
+5.7%
Q1 2020$3,361,000
-60.4%
1,162,876
-48.1%
3.55%
-40.0%
Q4 2019$8,494,000
+121.1%
2,241,239
+198.4%
5.92%
+58.8%
Q3 2019$3,841,000
-56.5%
751,012
-47.2%
3.73%
-38.7%
Q2 2019$8,826,000
+26.1%
1,423,578
+44.6%
6.08%
+50.9%
Q1 2019$6,999,000984,3294.03%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders